Upregulation of ATP-sensitive potassium channels for
estrogen-mediated cell proliferation in human uterine leiomyoma cells
- Author(s)
- SUNG-HEE PARK; SABARISH RAMACHANDRAN; SANG-HOON KWON; SOON-DO CHA; EUL WON SEO; INSOO BAE; CHIHEUM CHO; DAE-KYU SONG
- Keimyung Author(s)
- Song, Dae Kyu; Kwon, Sang Hoon; Cha, Soon Do; Cho, Chi Heum
- Department
- Dept. of Physiology (생리학)
Dept. of Obstetrics & Gynecology (산부인과학)
- Journal Title
- Gynecological Endocrinology
- Issued Date
- 2008
- Volume
- 24
- Issue
- 5
- Abstract
- Objectives. The objectives of the present study were to evaluate the expression level of ATP-sensitive potassium (KATP)
channels in smooth muscle cells in human uterine leiomyoma and the involvement of the channel in potentiating effect of
estrogen on leiomyoma growth.
Methods. Reverse transcription–polymerase chain reaction (RT-PCR), real-time PCR and Western blot were used for the
identification and quantification of KATP-channel subunits in the control myometrial and leiomyoma cells. Furthermore, we
measured the KATP-channel activity in enzymatically isolated single uterine smooth muscle cells by whole-cell patch-clamp
recordings. The estrogen-induced cell proliferation in leiomyoma was measured by the MTT assay.
Results. The subunits of KATP channels (Kir6.1, Kir6.2, SUR2B) were more highly expressed in leiomyoma cells than in
control cells. The whole-cell currents mainly through KATP channels were also greater in the leiomyoma cells. Estrogen
applied in the bath solution could acutely enhance the channel activity. Estrogen-induced proliferation of the leiomyoma cells
was inhibited by pretreatment with glibenclamide, a KATP-channel inhibitor.
Conclusion. Estrogen may induce the proliferation of leiomyoma cells, at least in part, by activating the KATP channel.
Increased expression of the KATP channel may be a causal factor for the high growth rate of uterine leiomyoma.
Keywords: Uterine leiomyoma, KATP channel, estrogen, cell proliferation
Introduction
Uterine leiomyoma (fibroids/myomas) is a common
problem, occurring in 40% of women older than 35
years. The availability of a safe and effective nonsurgical
treatment of leiomyoma would be of considerable
clinical and public health importance.
Uterine leiomyoma is a monoclonal tumor, and the
factors involved in its initiation and growth remain
poorly understood. Reports state that ovarian steroids,
i.e. progesterone and estrogen [1,2], participate
in the
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.